Insulin receptors and glucose uptake in the human parasite Schistosoma mansoni

Parasite

Volumn 15, Issue 4, 2008, Pages 573-579

  Ahier, A ^a   Khayath, N ^a   Vicogne, J ^b   Dissous, Colette ^a,c  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Glucose; Insulin receptor; Schistosoma mansoni; Tyrosine kinase inhibitor

Indexed keywords

SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 57849143437     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/2008154573     Document Type: Article

References (29)

1. BLUM G., GAZIT A. & LEVITZKI A. Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry, 2000, 39, 15705-15712.
2. BREHM K., SPILIOTIS M., ZAVALA-G ONGORA R., KONRAD C. & FROSCH M. The molecular mechanisms of larval cestode development: first steps into an unknown world. Parasitology International, 2006, 55 (Suppl.), S15-S21.
3. BRICHARD S.M., ASSIMACOPOULOS-JEANNET F. & JEANRENAUD B. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology, 1992, 131, 311-317.
4. BUEDING E. Carbohydrate metabolism of Schistosoma mansoni. The Journal of General Physiology, 1950, 33, 475-495.
5. CAFFREY C.R. Chemotherapy of schistosomiasis: present and future. Current Opinion in Chemical Biology, 2007, 11, 433-439.
6. CARAISCOS V.B., BONIN R.P., NEWELL J.G., CZERWINSKA E., MACDONALD J.F. & ORSER & B.A. Insulin increases the potency of glycine at ionotropic glycine receptors. Molecular Pharmacology, 2007, 71, 1277-1287.
7. CLEMENS L.E. & BASCH P.F. Schistosoma mansoni: insulin independence. Experimental Parasitology, 1999, 68, 223-229.
8. DE MENDONCA R.L., ESCRIVA H., BOUTON D., LAUDET V. & PIERCE R.J. Hormones and nuclear receptors in schistosome development. Parasitology Today, 2000, 16, 233-240.
9. DISSOUS C. & CAPRON A. Isolation and characterization of surface antigens from Schistosoma mansoni schistosomula. Molecular and Biochemical Parasitology, 1981, 3, 215-225.
10. DISSOUS C., KHAYATH N., VICOGNE J. & CAPRON M. Growth factor receptors in helminth parasites: signalling and host-parasite relationships. FEBS Letter, 2006, 580, 2968-2975.
11. DISSOUS C., AHIER A. & KHAYATH N. Protein tyrosine kinases as new potential targets against human schistosomiasis. Bioessays, 2007, 29, 1281-1288.
12. FENWICK A. & WEBSTER J.P. Schistosomiasis: challenges for control, treatment and drug resistance. Current Opinion in Infectious Diseases, 2006, 19, 577-582.
13. GRYSEELS B., POLMAN K., CLERINX J. & KESTENS L. Human schistosomiasis. Lancet, 2006, 368, 1106-1118.
14. KAPP K., KNOBLOCH J., SCHUSSLER P., SROKA S., LAMMERS R., KUNZ W. & GREVELDING C.G. The Schistosoma mansoni Src kinase TK3 is expressed in the gonads and likely involved in cytoskeletal organization. Molecular and Biochemical Parasitology, 2004, 138, 171-182.
15. KHAN A.H. & PESSIN J.E. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia, 2002, 45, 1475-1483.
16. KHAYATH N., VICOGNE J., AHIER A., BENYOUNES A., KONRAD C., TROLET J., VISCOGLIOSI E., BREHM K. & DISSOUS C. Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. Febs Journal, 2007, 274, 659-676.
17. KIM J.J. & ACCILI D. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm & IGF Research, 2002, 12, 84-90.
18. KING C.H., STURROCK R.F., KARIUKI H.C. & HAMBURGER J. Transmission control for schistosomiasis - why it matters now. Trends in Parasitology, 2006, 22, 575-582.
19. KNOBLOCH J., KUNZ W. & GREVELDING C.G. Herbimycin A suppresses mitotic activity and egg production of female Schistosoma mansoni. International Journal for Parasitology, 2006, 36, 1261-1272.
20. LEVI-SCHAFFER F. & SMOLARSKY M. Schistosoma mansoni: effect of insulin and a low-molecular-weight fraction of serum on schistosomula in chemically defined media. Experimental Parasitology, 1981, 52, 378-385.
21. LEVITZKI A. & GAZIT A. Tyrosine kinase inhibition: an approach to drug development. Science, 1995, 267, 1782-1788.
22. MORETTI L., TCHERNIN L. & SCAPOZZA L. Tyrosine kinase drug discovery: what can be learned from solved crystal structures? ARKIVOC VIII, 2006, 38-49.
23. NDEGWA D., KRAUTZ-PETERSON G. & SKELLY P.J. Protocols for gene silencing in schistosomes. Experimental Parasitology, 2007, 117, 284-291.
24. PARRIZAS M., GAZIT A., LEVITZKI A., WERTHEIMER E. & LEROITH D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology, 1997, 138, 1427-1433.
25. SKELLY P.J., KIM J.W., CUNNINGHAM J. & SHOEMAKER C.B. Cloning, characterization, and functional expression of cDNAs encoding glucose transporter proteins from the human parasite Schistosoma mansoni. Journal of Biological Chemistry, 1994, 269, 4247-4253.
26. SKELLY P.J. & SHOEMAKER C.B. Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni. Proceedings of the National Academy of Sciences, USA, 1996, 93, 3642-3646.
27. SKELLY P.J., DA'DARA A. & HARN D.A. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. International Journal for Parasitology, 2003, 33, 363-369.
28. VICOGNE J., CAILLIAU K., TULASNE D., BROWAEYS E., YAN Y.T., FAFEUR V., VILAIN J.P., LEGRAND D., TROLET J. & DISSOUS C. Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. Journal of Biological Chemistry, 2004, 279, 37407-37414.
29. VULPETTI A. & BOSOTTI R. Sequence and structural analysis of kinase ATP pocket residues. Farmaco, 2004, 59, 759-765.